Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

257.12
+2.120.83%
Post-market: 257.600.4800+0.19%19:57 EDT
Volume:4.31M
Turnover:1.11B
Market Cap:454.43B
PE:72.64
High:259.61
Open:253.92
Low:253.92
Close:255.00
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.00
T/O Rate:0.24%
Dividend:6.83
Dividend Rate:2.66%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-76.57
PE(LYR):108.95

Loading ...

Gubra H1 FY26 Operating Loss Widens to DKK 122.9 Million; Revenue Drops 95% to DKK 126.3 Million

Reuters
·
Aug 20

Movement Alert|AbbVie Rises 3.04% in Regular Trading, Multiple Banks Raise Price Targets Amid Pipeline Catalysts

Market Focus
·
Aug 20

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

AbbVie EVP, Chief Business and Strategy Officer Nicholas Donoghoe Disposes of 32,710 Common Shares Worth $8.18 Million

Reuters
·
Aug 19

AbbVie Raises $9 Billion Debt to Fund Acquisition

TIPRANKS
·
Aug 19

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

Reuters
·
Aug 19

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled

TradingKey
·
Aug 19

Movement Alert|AbbVie Rises 3.03% in Regular Trading, Multiple Banks Raise Price Targets Amid Pipeline Catalyst

Market Focus
·
Aug 19

AbbVie Sets Q3 2026 Distribution at R$ 0.38 Per Unit, Payable Aug. 20

Reuters
·
Aug 18

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

AbbVie is Maintained at Overweight by Wells Fargo

Dow Jones
·
Aug 17

Abbvie, Inc. : Wells Fargo Raises Target Price to $300 from $295

THOMSON REUTERS
·
Aug 17

Wells Fargo Adjusts Price Target on AbbVie to $300 From $295, Keeps Overweight Rating

MT Newswires Live
·
Aug 17

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors

TIPRANKS
·
Aug 15

AbbVie Wraps Real‑World China Study on Upadacitinib in Atopic Dermatitis: What Investors Should Watch

TIPRANKS
·
Aug 15

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

TIPRANKS
·
Aug 13

Wolfe Upgrades AbbVie to Outperform From Peer Perform, Price Target is $300

MT Newswires Live
·
Aug 13

What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?

Simply Wall St.
·
Aug 12